Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunotherapy for HIV infections].

Pr Yves Lévy1

  • 1Service d'immunologie clinique, Hôpital Henri Mondor 51, avenue du Maréchal de Lattre de Tassigny, 94010 Créteil.

Journal De La Societe De Biologie
|July 24, 2002
PubMed
Summary

New HIV therapies aim to boost immune response and reduce reliance on current antivirals. These strategies explore cytokines, immunomodulators, and therapeutic immunizations for better patient outcomes and fewer side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

[Food safety of GMOs].

Journal de la Societe de biologie·2010
Same journal

[Placing on the market, breeders rights and growing genetically modified (GM) varieties].

Journal de la Societe de biologie·2010
Same journal

[Cultivation and environmental impacts of GMO crops].

Journal de la Societe de biologie·2010
Same journal

[Applications of genetically modified animals].

Journal de la Societe de biologie·2010
Same journal

[Why GMOs].

Journal de la Societe de biologie·2010
Same journal

[Mutations in renin-angiotensin system genes and kidney developmental anomalies].

Journal de la Societe de biologie·2010

Area of Science:

  • Immunology
  • Virology
  • Pharmacology

Context:

  • HIV infection severely depletes CD4 T lymphocytes, leading to opportunistic infections.
  • Current antiviral therapies improve patient morbidity and mortality but have significant drawbacks like toxicity and resistance.
  • There is a critical need for alternative or complementary treatment strategies for HIV/AIDS.

Purpose:

  • To investigate novel therapeutic strategies beyond conventional antivirals for HIV infection.
  • To evaluate the potential of cytokines, immunomodulators, and therapeutic immunizations in managing HIV.
  • To explore methods for enhancing immune restoration and potentially reducing long-term antiviral use.

Summary:

  • Research is focused on developing new treatments for HIV, including the use of cytokines, immunomodulators, and therapeutic immunizations.
  • These novel approaches are being investigated for their ability to potentiate immune restoration in patients undergoing antiviral therapy.
  • The goal is to improve treatment efficacy, manage toxicity, and potentially decrease reliance on lifelong antiviral medications.

Impact:

  • These strategies may offer a way to enhance the effectiveness of existing antiviral treatments.
  • They could provide options to spare patients from or delay the need for long-term antiviral drug use.
  • Successful development could lead to improved quality of life and long-term management of HIV infection.

Related Experiment Videos